Adjunctive inhaled amikacin in infants with ventilator-associated pneumonia optimizes the complex antimicrobial therapy: pilot study

BACKGROUND AND AIM: VAP remains the second leading cause of death among the patients with nosocomial infections and its incidence varies significantly from 5% to 60% reaching on average 10%. It is of crucial importance to develop novel treatment approaches and optimize the existing ones. Thus, the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Levchenko, Bohdan, Nazarchuk, Oleksandr, Dmytriiev, Dmytro, Bahniuk, Natalia, Melnychenko, Mykola, Dmytriiev, Kostiantyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210574/
https://www.ncbi.nlm.nih.gov/pubmed/37092633
http://dx.doi.org/10.23750/abm.v94i2.13910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210574/
https://www.ncbi.nlm.nih.gov/pubmed/37092633
http://dx.doi.org/10.23750/abm.v94i2.13910

Ejemplares similares